Genos Ltd – Zagreb, Croatia

A knowledge-based company

Genos employs 8 researchers with PhD and 9

PhD students

MislavAna MajaVedrana

Petar Julija Ivona

Jasminka

Irena Lucija

Jerko

Frano

Snježana

Ivan

Genos is a SME partner in six FP7 grants

Eficient patient stratification is the holy grail of modern medicine

Genome wide association studies initiated revolution in

genetics

DNA is only one of the four principal components of the cell

A B C

Glycans are important structural and functional component of nearly

all proteins

Genos is the global leader in high-throughput glycomics

High-throughput glycomics is globally deficient

LUMCNIBRT

Only three labs published glycomic studies on over 1000 individuals

Genos

The first population study of the human plasma glycome

The first population study of the human IgG glycome

The first GWAS of the human glycome

The first GWAS of the IgG glycome

The first human study linking glycome with epigenetics

Support from the FP7 programme was essential for the

success of Genos

GlycoBioGen consortium

Alan WrightNick Hastie

Harry CampbellJim WilsonIgor RudanPauline Rudd

Mark McCarthy

Ulf Gyllensten

Wei Wang

Vlatka ZoldošKristian Vlahoviček

Manfred WuhrerJeanine Houwing

Dermot McGovern

Tim Spector

Nish Chaturvedi

Nenad Šestan

Rapid development of new products

and services Collaboration with

leading academic institutions (our

partners in EU projects) gives Genos access to

unique resources

GlycanAge® index explains up to 60% of age

variance

Patent pending P20130568A

Discoveries from EU research projects enable Genos to

develop proprietary new products

New biomarkers for patient stratification

1 - Specificity

0.0 0.2 0.4 0.6 0.8 1.0

Sen

sitiv

ity

0.0

0.2

0.4

0.6

0.8

1.0

Test 1, A = 0.94

AUC=0.94

1 - Specificity

0.0 0.2 0.4 0.6 0.8 1.0

Sen

sitiv

ity

0.0

0.2

0.4

0.6

0.8

1.0

Test 1, A = 0.90

AUC=0.90

T2DM T1DM

DG8 DG9

Thanabalasingham et al, Diabetes, 2013

EU research projects enables us to bring our new glycan biomarkers

closer to market

Genos - the most innovative small company

in Croatia

Genos was one of the five finalists for 2013 Innovation

Prize in Paris

Genos is the best place to work for researchers in

industry

2007 – 2012

2006 2007 2008 2009 2010 2011 2012 20130

1000000

2000000

3000000

4000000

5000000

6000000

7000000

8000000

0

5

10

15

20

25

Income Employees

Support from the FP7 programme was essential for the

success of Genos